Design, develop, manufacture and commercialize innovative products based on high performance microelectromechanical systems (MEMS). ISSYS' products provide the highest accuracy, fit the smallest sizes...
Sarastro GmbH was founded in 2001. Core competence is in applied chemical nanotechnology for medicine, medical techniques, life science, hygiene, cosmetics and food. On the base of a conservative...
Australian company, AorTech Biomaterials Pty Ltd manufactures highly stable, highly biocompatible polymeric materials that are used in the medical device, pharmaceutical and biotechnology industries....
Nano Bridging Molecules S.A. ('NBM') is devoted to researching, developing,
manufacturing, and marketing its patented SurfLink® range of advanced medical
implant surface modifications designed...
Applying nanotechnology methods in the area of materials can result in the creation of novel materials with new, unique and exciting properties. The classification and composition of nanomaterials,...
http://www.azonano.com/article.aspx?ArticleID=1287 | 28 Jun 2005
There are several different methods of classification for nanomaterials according to dimension, phase composition and the manufacturing process. This article focuses on the categorisation of...
http://www.azonano.com/article.aspx?ArticleID=1073 | 10 Dec 2004
In cancer research, nanotechnology holds great promise for the development
of targeted, localized delivery of anticancer drugs, in which only cancer cells
are affected. By carrying out...
http://www.azonano.com/news.aspx?newsID=19073 | 18 Aug 2010
Markets, the leading source for international market research and market
data, has announced the addition of the "carbon nanotubes handbook"
report to their...
http://www.azonano.com/news.aspx?newsID=14384 | 29 Oct 2009
The biological safety of nanotechnology, in other words, how the body reacts
to nanoparticles, is a hot topic. Researchers at Lund
University in Sweden have managed for the first time to carry...
http://www.azonano.com/news.aspx?newsID=14275 | 22 Oct 2009
Robert S. Schwartz, MD, medical director of the Minnesota Cardiovascular
Research Institute, Minneapolis Heart Institute Foundation, will describe the
new paradigm of the biocompatibility of...
http://www.azonano.com/news.aspx?newsID=12079 | 15 Jun 2009